Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-00408 | Azido-PEG2-PFP ester | 1393330-37-4 |
| Azido-PEG2-PFP ester is a mixture of azide-functionalized polyethylene glycol (PEG) derivatives interleaved with pentafluorophenyl (PFP) ester moieties. This special compound is widely used as a coupling agent in the field of bioconjugation chemistry and shows unparalleled potential in efficient biomolecule modification. Whether proteins or peptides, azido-PEG2-PFP esters open up many possibilities for revolutionary applications, including drug delivery systems, targeted therapies, and transformative diagnostics. | Inquiry | |
| BADC-00411 | 5-azidopentanoic acid N-hydroxysuccinimide ester | 478801-48-8 |
| 5-azidopentanoic acid N-hydroxysuccinimide ester is an important entity in the biomedical field and plays a key role. This compound has multiple uses as a catalyst for bioconjugation and protein labeling, triggering the specific binding of a drug or biomolecule to its intended receptor. This advantage ultimately facilitates the delivery of targeted drugs while refining diagnostic methods. | Inquiry | |
| BADC-00412 | 3-azidopropanoate-N-hydroxysuccinimide ester | 850180-76-6 |
| 3-azidopropanoate-N-hydroxysuccinimide ester is a small molecule reagent. As a versatile reactive reagent, it has a significant impact on bioconjugation and cross-linking applications. It is deeply embedded in the synthetic mechanism of drug delivery systems, effectively achieving precise targeted release of therapeutic drugs. | Inquiry | |
| BADC-00413 | NHS-Ac-N3 | 824426-32-6 |
| NHS-Ac-N3 is a paramount reagent within biomedicine and emerges as an exquisite modulator for drug advancement and biomolecule conjugation. This compound has unique chemical properties that play a key role in the fusion of multiple drugs and bioconjugates, aiding in the development of effective treatments for diseases such as cancer, neurodegenerative diseases, and infectious diseases. | Inquiry | |
| BADC-00420 | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate | |
| Perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate is an exquisite biomedical chemical. Its extraordinary attributes make it a prime candidate for drug delivery systems, facilitating targeted release of therapeutic agents. By enabling precise localization within the body, it exhibits remarkable prowess in combating diverse conditions. | Inquiry | |
| BADC-00421 | 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate | |
| 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12,15-tetraoxa-3-azaoctadecan-18-oate is a highly intricate and multifaceted substance that emerges as an exceedingly powerful agent employed within the biomedical realm. Manifesting its efficacy in combating a myriad of ailments including cancer, inflammation, and bacterial infections, this compound boasts the capacity to extensively navigate and perturb distinct biochemical routes intrinsic to cellular mechanisms. | Inquiry | |
| BADC-00422 | perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate | |
| perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate is a biomedical product for cancer drug development. It exhibits potent inhibitory effects against specific tumor cells, enhancing their susceptibility to chemotherapy. This product's unique chemical properties aid in delivering targeted therapies to tumor sites, minimizing off-target effects. | Inquiry | |
| BADC-00423 | 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate | |
| 2,5-dioxopyrrolidin-1-yl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate is a remarkable biomedical entity. Its capacity to impede specific signaling pathways associated with neoplastic proliferation and advancement has endowed it with considerable prospects for combating a myriad of cancers. Furthermore, the compound's exceptional attributes extend to its ability to combat multidrug-resistant microbial strains, thus reinforcing its significance in the relentless battle against infectious agents. | Inquiry | |
| BADC-00424 | perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate | |
| Perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate is a widely used biomedical agent. Due to its special chemical properties and composition, it represents a typical tool in the biomedical field. This exquisite entity has demonstrated its potential as a powerful drug, adept at effectively targeting unique cellular pathways and receptors responsible for treating a variety of diseases. | Inquiry | |
| BADC-00425 | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate | |
| 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate is a pharmaceutical compound widely used in the biomedical field. Its powerful medicinal properties are effective against drug-resistant strains, especially in overcoming Gram-positive infections. | Inquiry | |
| BADC-00428 | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate | 1006592-59-1 |
| 2,5-dioxopyrrolidin-1-yl 3-(2-(2-undec-10-ynamidoethoxy)ethoxy)propanoate is a small molecule compound. It has attracted great attention in the biomedical field because of its remarkable ability to fight bacterial infections. Its unparalleled efficacy in precisely targeting drug delivery systems and amplifying therapeutic effects has been extensively documented through comprehensive research. | Inquiry | |
| BADC-00429 | 2,5-dioxopyrrolidin-1-yl 7,10,13-trioxa-4-azahexadec-1-yn-16-oate | 1214319-94-4 |
| 2,5-Dioxopyrrolidin-1-yl 7,10,13-trioxa-4-azahexadec-1-yn-16-oate is a compound widely employed within the biomedical sector and exhibits promising implications for diverse maladies and ailments. Owing to its exceptional ability to target distinct drug receptors and pathways, this chemical entity unveils itself as a prospective therapeutic agent. | Inquiry | |
| BADC-00430 | Propargyl-PEG4-NHS ester | 1428629-70-2 |
| Inquiry | ||
| BADC-00432 | Propargyl-O-C1-amido-PEG3-C2-NHS ester | 2101206-78-2 |
| Propargyl-O-C1-amido-PEG3-C2-NHS ester is a non-cleavable 3-unit PEG linker that can be used to synthesize antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00434 | 5-hexynoic NHS ester | 906564-59-8 |
| Inquiry | ||
| BADC-00435 | 4-pentynoic acid succinimidyl ester | 132178-37-1 |
| 4-Pentynoic acid succinimidyl ester is a biomedicine product extensively utilized in the pharmaceutical industry. It acts as a pivotal reagent facilitating the derivatization of diverse drugs and molecules. This compound has the ability to form stable amide bonds and is an important tool in drug discovery and bioconjugation research. The remarkable versatility of this compound fuels the advancement of targeted therapeutic approaches, diagnostic instruments, and drug conveyance mechanisms. | Inquiry | |
| BADC-00436 | Mal-Ph-CONH-PEG4-NHS ester | 1263044-88-7 |
| Mal-Ph-CONH-PEG4-NHS ester is a non-cleavable 4-unit PEG ADC linker that is used in the synthesis of antibody-conjugated drugs (ADCs). | Inquiry | |
| BADC-00437 | 2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate | 1232769-29-7 |
| 2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1 -oate is an innovative biomedical chemical. Utilizing its unique chemical composition, it actively disrupts malignant molecular pathways to prevent tumor proliferation. Its superb targeted delivery capabilities act as a catalyst, amplifying the therapeutic effects and propelling it to the forefront of promising targeted cancer treatment candidates. | Inquiry | |
| BADC-00438 | MAL-Di-EG-OPFP | 1347750-81-5 |
| MAL-Di-EG-OPFP is a fluorescent dye widely used in the biomedical field and has extensive uses in biomolecular labeling and research on complex cellular mechanisms. This exceptional product significantly contributes to the advancement of pharmacological breakthroughs while addressing critical needs in disease diagnosis, including cancer and neurodegenerative diseases. | Inquiry | |
| BADC-00439 | MC-PEG2-C2-NHS ester | 1263044-56-9 |
| MC-PEG2-C2-NHS ester is a non-cleavable 2-unit PEG linker that is used in the synthesis of antibody-conjugated drugs (ADCs). | Inquiry |
